218 related articles for article (PubMed ID: 16003466)
21. Definition of supertypes for HLA molecules using clustering of specificity matrices.
Lund O; Nielsen M; Kesmir C; Petersen AG; Lundegaard C; Worning P; Sylvester-Hvid C; Lamberth K; Røder G; Justesen S; Buus S; Brunak S
Immunogenetics; 2004 Mar; 55(12):797-810. PubMed ID: 14963618
[TBL] [Abstract][Full Text] [Related]
22. Divergent Peptide Presentations of HLA-A
Zhu S; Liu K; Chai Y; Wu Y; Lu D; Xiao W; Cheng H; Zhao Y; Ding C; Lyu J; Lou Y; Gao GF; Liu WJ
Front Immunol; 2019; 10():1709. PubMed ID: 31396224
[TBL] [Abstract][Full Text] [Related]
23. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
Kast WM; Brandt RM; Sidney J; Drijfhout JW; Kubo RT; Grey HM; Melief CJ; Sette A
J Immunol; 1994 Apr; 152(8):3904-12. PubMed ID: 7511661
[TBL] [Abstract][Full Text] [Related]
24. Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution.
Sette A; Sidney J; Livingston BD; Dzuris JL; Crimi C; Walker CM; Southwood S; Collins EJ; Hughes AL
Immunogenetics; 2003 Mar; 54(12):830-41. PubMed ID: 12671733
[TBL] [Abstract][Full Text] [Related]
25. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
[TBL] [Abstract][Full Text] [Related]
26. Distinct Polymorphisms in HLA Class I Molecules Govern Their Susceptibility to Peptide Editing by TAPBPR.
Ilca FT; Drexhage LZ; Brewin G; Peacock S; Boyle LH
Cell Rep; 2019 Nov; 29(6):1621-1632.e3. PubMed ID: 31693900
[TBL] [Abstract][Full Text] [Related]
27. A framework to sub-type HLA supertypes.
Kangueane P; Sakharkar MK; Rajaseger G; Bolisetty S; Sivasekari B; Zhao B; Ravichandran M; Shapshak P; Subbiah S
Front Biosci; 2005 Jan; 10():879-86. PubMed ID: 15569626
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for HLA-A2 supertypes.
Kangueane P; Sakharkar MK
Methods Mol Biol; 2007; 409():155-62. PubMed ID: 18449998
[TBL] [Abstract][Full Text] [Related]
29. Application of genetic search in derivation of matrix models of peptide binding to MHC molecules.
Brusic V; Schönbach C; Takiguchi M; Ciesielski V; Harrison LC
Proc Int Conf Intell Syst Mol Biol; 1997; 5():75-83. PubMed ID: 9322018
[TBL] [Abstract][Full Text] [Related]
30. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8.
DiBrino M; Parker KC; Shiloach J; Turner RV; Tsuchida T; Garfield M; Biddison WE; Coligan JE
J Immunol; 1994 Jan; 152(2):620-31. PubMed ID: 7506728
[TBL] [Abstract][Full Text] [Related]
31. HLAsupE: an integrated database of HLA supertype-specific epitopes to aid in the development of vaccines with broad coverage of the human population.
Wang S; Guo L; Liu D; Liu W; Wu Y
BMC Immunol; 2016 Jun; 17(1):17. PubMed ID: 27307005
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration.
Tanaka M; Tanaka K; Tsuji S; Kawata A; Kojima S; Kurokawa T; Kira J; Takiguchi M
J Neurol Sci; 2001 Jul; 188(1-2):61-5. PubMed ID: 11489286
[TBL] [Abstract][Full Text] [Related]
33. Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype.
Hillen N; Mester G; Lemmel C; Weinzierl AO; Müller M; Wernet D; Hennenlotter J; Stenzl A; Rammensee HG; Stevanović S
Eur J Immunol; 2008 Nov; 38(11):2993-3003. PubMed ID: 18991276
[TBL] [Abstract][Full Text] [Related]
34. Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires.
Gleimer M; Wahl AR; Hickman HD; Abi-Rached L; Norman PJ; Guethlein LA; Hammond JA; Draghi M; Adams EJ; Juo S; Jalili R; Gharizadeh B; Ronaghi M; Garcia KC; Hildebrand WH; Parham P
J Immunol; 2011 Feb; 186(3):1575-88. PubMed ID: 21209280
[TBL] [Abstract][Full Text] [Related]
35. Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing.
Maier R; Falk K; Rötzschke O; Maier B; Gnau V; Stevanović S; Jung G; Rammensee HG; Meyerhans A
Immunogenetics; 1994; 40(4):306-8. PubMed ID: 7521860
[No Abstract] [Full Text] [Related]
36. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
[TBL] [Abstract][Full Text] [Related]
37. The Utility of Supertype Clustering in Prediction for Class II MHC-Peptide Binding.
Shen WJ; Zhang X; Zhang S; Liu C; Cui W
Molecules; 2018 Nov; 23(11):. PubMed ID: 30463372
[TBL] [Abstract][Full Text] [Related]
38. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules.
Kondo A; Sidney J; Southwood S; del Guercio MF; Appella E; Sakamoto H; Celis E; Grey HM; Chesnut RW; Kubo RT; Sette A
J Immunol; 1995 Nov; 155(9):4307-12. PubMed ID: 7594589
[TBL] [Abstract][Full Text] [Related]
39. HLA supertype variation across populations: new insights into the role of natural selection in the evolution of HLA-A and HLA-B polymorphisms.
Dos Santos Francisco R; Buhler S; Nunes JM; Bitarello BD; França GS; Meyer D; Sanchez-Mazas A
Immunogenetics; 2015 Nov; 67(11-12):651-63. PubMed ID: 26459025
[TBL] [Abstract][Full Text] [Related]
40. Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype.
Røder G; Blicher T; Justesen S; Johannesen B; Kristensen O; Kastrup J; Buus S; Gajhede M
Acta Crystallogr D Biol Crystallogr; 2006 Nov; 62(Pt 11):1300-10. PubMed ID: 17057332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
